Safety of a Novel Gel Formulation of Clindamycin Phosphate 1.2%–Tretinoin 0.025%: Results From a 52-Week Open-Label Study

Article Type
Changed
Thu, 01/10/2019 - 12:16
Display Headline
Safety of a Novel Gel Formulation of Clindamycin Phosphate 1.2%–Tretinoin 0.025%: Results From a 52-Week Open-Label Study

Article PDF
Author and Disclosure Information

Kircik LH, Peredo MI, Bucko AD, Loss RW Jr, Fowler JF Jr, Wortzman M, Neumaier GJ

Issue
Cutis - 82(5)
Publications
Topics
Page Number
358-366
Sections
Author and Disclosure Information

Kircik LH, Peredo MI, Bucko AD, Loss RW Jr, Fowler JF Jr, Wortzman M, Neumaier GJ

Author and Disclosure Information

Kircik LH, Peredo MI, Bucko AD, Loss RW Jr, Fowler JF Jr, Wortzman M, Neumaier GJ

Article PDF
Article PDF

Issue
Cutis - 82(5)
Issue
Cutis - 82(5)
Page Number
358-366
Page Number
358-366
Publications
Publications
Topics
Article Type
Display Headline
Safety of a Novel Gel Formulation of Clindamycin Phosphate 1.2%–Tretinoin 0.025%: Results From a 52-Week Open-Label Study
Display Headline
Safety of a Novel Gel Formulation of Clindamycin Phosphate 1.2%–Tretinoin 0.025%: Results From a 52-Week Open-Label Study
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

A Patch Test Study to Evaluate the Allergenicity of a Metallic Jewelry Alloy in Patients Allergic to Cobalt

Article Type
Changed
Tue, 05/07/2019 - 15:00
Display Headline
A Patch Test Study to Evaluate the Allergenicity of a Metallic Jewelry Alloy in Patients Allergic to Cobalt

Article PDF
Author and Disclosure Information

Perryman JH, Fowler JF Jr

Issue
Cutis - 77(2)
Publications
Topics
Page Number
77-80
Sections
Author and Disclosure Information

Perryman JH, Fowler JF Jr

Author and Disclosure Information

Perryman JH, Fowler JF Jr

Article PDF
Article PDF

Issue
Cutis - 77(2)
Issue
Cutis - 77(2)
Page Number
77-80
Page Number
77-80
Publications
Publications
Topics
Article Type
Display Headline
A Patch Test Study to Evaluate the Allergenicity of a Metallic Jewelry Alloy in Patients Allergic to Cobalt
Display Headline
A Patch Test Study to Evaluate the Allergenicity of a Metallic Jewelry Alloy in Patients Allergic to Cobalt
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Hydrocortisone Butyrate 0.1% Cream in the Treatment of Chronic Dermatitis

Article Type
Changed
Thu, 01/10/2019 - 12:04
Display Headline
Hydrocortisone Butyrate 0.1% Cream in the Treatment of Chronic Dermatitis

Article PDF
Author and Disclosure Information

Fowler JF Jr, Fransway AF, Jackson JM, Rohowsky N

Issue
Cutis - 75(2)
Publications
Topics
Page Number
125-131
Sections
Author and Disclosure Information

Fowler JF Jr, Fransway AF, Jackson JM, Rohowsky N

Author and Disclosure Information

Fowler JF Jr, Fransway AF, Jackson JM, Rohowsky N

Article PDF
Article PDF

Issue
Cutis - 75(2)
Issue
Cutis - 75(2)
Page Number
125-131
Page Number
125-131
Publications
Publications
Topics
Article Type
Display Headline
Hydrocortisone Butyrate 0.1% Cream in the Treatment of Chronic Dermatitis
Display Headline
Hydrocortisone Butyrate 0.1% Cream in the Treatment of Chronic Dermatitis
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Pimecrolimus Cream 1%: A Potential New Treatment for Chronic Hand Dematitis

Article Type
Changed
Thu, 01/10/2019 - 12:00
Display Headline
Pimecrolimus Cream 1%: A Potential New Treatment for Chronic Hand Dematitis

Article PDF
Author and Disclosure Information

Donald V. Belsito, MD; Joseph F. Fowler, Jr, MD; James G. Marks, Jr, MD; David M. Pariser, MD; Jon Hanifin, MD; Ida Alzira Gomes Duarte, MD; Mario C. Pires, MD; Ponciano D. Cruz, Jr, MD; Richard G.B. Langley, MD; Premal Patel, BS; Christopher Bush, PhD; Mark Thurston, MSc; Michael Graeber, MD; Robert Cherill, MS; and the Multicenter Investigator Group

Issue
Cutis - 73(1)
Publications
Topics
Page Number
31-38
Sections
Author and Disclosure Information

Donald V. Belsito, MD; Joseph F. Fowler, Jr, MD; James G. Marks, Jr, MD; David M. Pariser, MD; Jon Hanifin, MD; Ida Alzira Gomes Duarte, MD; Mario C. Pires, MD; Ponciano D. Cruz, Jr, MD; Richard G.B. Langley, MD; Premal Patel, BS; Christopher Bush, PhD; Mark Thurston, MSc; Michael Graeber, MD; Robert Cherill, MS; and the Multicenter Investigator Group

Author and Disclosure Information

Donald V. Belsito, MD; Joseph F. Fowler, Jr, MD; James G. Marks, Jr, MD; David M. Pariser, MD; Jon Hanifin, MD; Ida Alzira Gomes Duarte, MD; Mario C. Pires, MD; Ponciano D. Cruz, Jr, MD; Richard G.B. Langley, MD; Premal Patel, BS; Christopher Bush, PhD; Mark Thurston, MSc; Michael Graeber, MD; Robert Cherill, MS; and the Multicenter Investigator Group

Article PDF
Article PDF

Issue
Cutis - 73(1)
Issue
Cutis - 73(1)
Page Number
31-38
Page Number
31-38
Publications
Publications
Topics
Article Type
Display Headline
Pimecrolimus Cream 1%: A Potential New Treatment for Chronic Hand Dematitis
Display Headline
Pimecrolimus Cream 1%: A Potential New Treatment for Chronic Hand Dematitis
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Systemic Contact Dermatitis Caused by Oral Chromium Picolinate

Article Type
Changed
Thu, 01/10/2019 - 11:45
Display Headline
Systemic Contact Dermatitis Caused by Oral Chromium Picolinate
Article PDF
Issue
Cutis - 65(2)
Publications
Topics
Page Number
116
Article PDF
Article PDF
Issue
Cutis - 65(2)
Issue
Cutis - 65(2)
Page Number
116
Page Number
116
Publications
Publications
Topics
Article Type
Display Headline
Systemic Contact Dermatitis Caused by Oral Chromium Picolinate
Display Headline
Systemic Contact Dermatitis Caused by Oral Chromium Picolinate
Disallow All Ads
Alternative CME
Article PDF Media